Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
CNBP - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Myotonic dystrophy 2, 602668, Autosomal dominant; DM2 (Proximal myotonic myopathy)(Repeat Analysis) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Variantyx, Inc. United States | 5 | 3 |
|
Myotonic dystrophy type 2 (CCTG expansion on CNBP/ZNF9 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Molecular Genetics Laboratory BC Children's and BC Women's Hospitals Canada | 1 | 1 |
|
Myotonic Dystrophy 2 (ZNF9/CNBP) Genetic Testing (Repeat Expansion) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 1 | 1 |
|
GeneDx United States | 1 | 1 |
|
Myotonic dystrophy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
Myotonic Dystrophy Type 2 (CNBP) Repeat Expansion Fulgent Genetics United States | 1 | 1 |
|
CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario Canada | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 0 |
|
Myotonic Syndrome Advanced Evaluation Athena Diagnostics United States | 9 | 7 |
|
Bioarray Spain | 1 | 1 |
|
MVZ Dr. Eberhard & Partner Dortmund Germany | 1 | 1 |
|
MVZ Dr. Eberhard & Partner Dortmund Germany | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Athena Diagnostics United States | 1 | 1 |
|
Fulgent Genetics United States | 5130 | 4674 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.